Home > Category > Signaling Pathways > Membrane Transporter/Ion Channel > SGLT > Sergliflozin etabonate | GW-869682X

Sergliflozin etabonate | GW-869682X

ChemLeader 98+%

Catalog No：CL2093 CAS No.：408504-26-7 MDLNo： Formula：C23H28O9 MW：448.46

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Sergliflozin etabonate \| GW-869682X
CAS	408504-26-7
Formula	C23H28O9
MW	448.46
Appearance	White to off-white powder
Storage condition	4°C, protect from light

Product details

Sergliflozin etabonate (KGT-1251) is an inhibitor of SGLT2 and can be used in studies about type 2 diabetes and obesity.

Related literature

Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study.

PMID: 20200268 DOI: 10.1177/0091270009352185

Read more

Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-A(y) mice.

PMID: 19615995 DOI: 10.1016/j.ejphar.2009.07.001

Read more

Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats.

PMID: 19281809 DOI: 10.1016/j.ejphar.2009.03.007

Read more

Related

Sorry, no related items

History

Sergliflozin etabonate | GW-869682X

408504-26-7 98+%

trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]-cyclohexaneacetic acid

1109276-89-2 98+%

S-(-)-Carbidopa | Carbidopa

28860-95-9 98+%

Cefmetazole | CS 1170

56796-20-4 98+%

Cytochalasin H(CytH)

53760-19-3 95+% HPLC